16
Participants
Start Date
January 27, 2025
Primary Completion Date
May 22, 2025
Study Completion Date
May 22, 2025
Numeta G16%E
Numeta G16%E (1000mL) will be given intravenously via peripherally inserted central catheter and will provide an equimolar IV phosphate dose of 8.7 mmol over 9 h.
Sodium Glycerophosphate Injection
Organic phosphate (SGP) will be diluted 1000mL of sodium chloride (0.9% normal saline) to achieve an equimolar IV phosphate dose of 8.7 mmol over 9 h.
Austin PPD CRU, Austin
Baxter Healthcare Corporation
INDUSTRY